Imbed Biosciences Inc. is a privately held medical device company and innovator of SAMatrix™ Technology, with both commercially available and emerging pipeline solutions.

Imbed is changing the paradigm of wound care with its revolutionary SAMatrix™ platform technology that integrates multiple wound care agents into an ultra-thin, fully synthetic matrix composed of bioresorbable fibers. SAMatrix™ is designed to help protect wounds and facilitate wound healing.

Imbed’s current SAMatrix™ portfolio includes Surgaflex^®, Pelashield^®, and Microlyte^®, with antimicrobial silver integrated into the matrix. The portfolio now also includes Microlyte^® PainGuard^®, Pelashield^® PainGuard^®, and Surgaflex^® PainGuard^®, with the addition of lidocaine HCl to manage pain along with bioburden reduction. These brands are indicated across a wide range of chronic and acute wounds, including ulcers, surgical, traumatic, and burn wounds.

Imbed Biosciences is registered with the U.S. FDA as a medical device manufacturer and maintains an ISO 13485:2016 certified Quality Management System.